Max-Planck Gesellschaft zur Förderung der Wissenschaften e.V.
The Max Planck Society (MPG) is Germany's most successful research organization with more than 15,000 annual publications in internationally renowned, scientific journals. The Max-Planck-Institute for Multidisciplinary Sciences in Göttingen is an internationally leading research institute of exceptional scientific breadth and since 2022 the largest institute of the Max Planck Society. The new institute comprises more than 40 research groups and employs around 1,000 people from over 50 nations. The research of the Max-Planck-Institute for Multidisciplinary Sciences, hosting the interdisciplinary group “Translational Molecular Imaging” at the City Campus is focused on the understanding of molecular mechanisms underlying pathological processes of different diseases to design novel diagnostic and therapeutic approaches with a “bench to bedside” strategy. The MPI is engaged in graduate schools e.g. Molecular Biology/ Neurosciences, MP School of Photonics, Graduate Center for Neurosciences, Biophysics, Molecular Biosciences.
Role within Screen4Care
Within the Screen4Care project, the MPG partner will contribute with new high-resolution imaging techniques on whole tissue biopsies to enrich phenotypic profiles for complex and underpowered samples. Standardized protocols will be established for multiphoton microscopy and x-ray phase-contrast tomography (WP2.4; D4.5). The resulting deep phenotypes will be used to enrich models of the digital diagnosis algorithm.